ERVW-1 and dengue disease: However, ED3 is not as immunogenic as the entire envelope protein [13]; therefore, some enhancements are required for ED3-based dengue vaccines, including the addition of a signal peptide for secretion [13] or other dengue proteins containing T-cell epitopes [14, 15] and the use of an adjuvant.